@FierceBiotech: Reborn Akari grabs $75M in financing for another Soliris rival. Article | Follow @FierceBiotech
@JohnCFierce: I'm sure the FDA feels ever so much better now that Addyi is in Valeant's hands. Oh yeah. | Follow @JohnCFierce
@DamianFierce: Turing has a new Form D reflecting that $90M claim but now including warrants and a loan. SEC filing | Follow @DamianFierce
> Roche ($RHHBY) has reached out to Janus Biotherapeutics to collaborate on a small-molecule treatment for autoimmune disease. More
> Gene sequencing outfit Adaptive Biotechnologies is getting into drug development, launching a new subsidiary called Adaptive Therapeutics to advance some cell therapies for cancer. Item
> Applied Genetic Technologies ($AGTC) closed its deal with Biogen ($BIIB), worth up to $1 billion in total, and saw its share price rise as much as 22%. News
Medical Device News
@FierceMedDev: BioDelivery snags new FDA approval for Onsolis after ditching Meda partnership. FierceDrugDelivery story | Follow @FierceMedDev
@VarunSaxena2: Edge files for up to $115M IPO to support locally delivered med for brain aneurysms. ICYMI from FierceDrugDelivery | Follow @VarunSaxena2
@EmilyWFierce: $ILMN CEO Flatley opens up about Helix and "app store" for human genomes. MIT Technology Review article | Follow @EmilyWFierce
> LDR raises $86.5M to back ongoing launch of cervical disc replacement device. More
> Boston Sci earns FDA approval of Innova stent to treat peripheral artery disease. Article
Pharma News
@FiercePharma: Horizon puts forth its slate of new Depomed directors. Story | Follow @FiercePharma
@EricPFierce: FDA warning letter castigates three Mylan sterile drug plants in India. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: In case you missed my foray into Google Forms, we're doing a survey on the next M&A move from $AGN. More | Follow @CarlyHFierce
> In a first for diabetes, Lilly and Boehringer's Jardiance prevents heart attacks, strokes in trial. Story
> Valeant sizes up women's health with $1B deal for Sprout and its libido drug. Article
Vaccines News
> Pfenex enters anthrax vaccines realm with $143.5M BARDA contract. News
> NIAID funds Soligenix with $2.7M in ricin vaccine effort. Report
> Team outlines potential target for aggressive breast cancer vaccine. Item
> WHO: Vaccine hesitancy is a mounting challenge for immunization programs. More
> Inovio's MERS vaccine shows 100% protection in mice, camels, monkeys. Article
CRO News
> Evotec's hybrid R&D model keeps revenue rolling. More
> U.K. CRO conglomerate bags another testing outfit with eyes on toxicology. Story
> Actelion taps DKSH to break into Asia. Item
> WuXi watches profits slip on its way to going private. Article
Pharma Manufacturing News
> Aurobindo lays out plans for 3 new plants. Item
> Mylan expands recalls from plants spanked in FDA warning letter. Article
> Merck recalls 276,000 bottles of cancer med that could pose risk to children. News
> Indonesia's Kimia to build $71M plant to make herbal meds. Story
> Union posts email exchange with Merck CEO over plant dangers from job cuts. Article
Pharma Asia News
> SK Chemicals ready to sell home-grown influenza vaccine as season gets underway. Report
> Mylan sees three Indian plants under FDA scanner on quality. Story
> Australia's Benitec prices Nasdaq IPO at $9.21 a share. Article
> Singapore's Asian American Medical eyes oncology expansion in southern China. More
> Australia's TGA registers Hospira's Inflectra. Item